ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
139 hedge funds and large institutions have $1.19B invested in Intra-Cellular Therapies Inc. in 2016 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 58 increasing their positions, 28 reducing their positions, and 16 closing their positions.
Holders
139
Holders Change
+12
Holders Change %
+9.45%
% of All Funds
3.71%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
29
Increased
58
Reduced
28
Closed
16
Calls
$22.7M
Puts
$14.6M
Net Calls
+$8.1M
Net Calls Change
+$13.5M
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$91.4M |
| 2 |
BB
2
BB Biotech
Schaffhausen,
Switzerland
|
$27.2M |
| 3 |
O
3
OrbiMed
New York
|
$34.4M |
| 4 |
EC
4
EcoR1 Capital
San Francisco,
California
|
$9.51M |
| 5 |
5
Norges Bank
Oslo,
Norway
|
$7.65M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
LCM
151
Laurion Capital Management
New York
| – | – | -7,400 | Closed |
|
152
SG Americas Securities
New York
| – | – | -4,188 | Closed |
|
|
MAM
153
Meeder Asset Management
Dublin,
Ohio
| – | – | -3,574 | Closed |
|
|
PAM
154
Paradigm Asset Management
New York
| – | – | -2,000 | Closed |
|
155
Simplex Trading
Chicago,
Illinois
| – | – | -1,867 | Closed |
|
156
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | – | – | – |
|
157
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|